Clinical Trials Browser

Phase 2 × Platinum-sensitive Ovarian Cancer × olaparib × Clear all

NCT06686030 2025-04-16

Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

Phase 2 Recruiting

Platinum-sensitive Ovarian Cancer